查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1614237

马医疗保健市场：按产品、应用和最终用户 - 2025-2030 年全球预测

Equine Healthcare Market by Product (Diagnostics tools, Feed Supplements, Pharmaceuticals), Application (Diagnosis, Monitoring & Therapy, Surgical Application), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年马医疗保健市场规模为32.5亿美元，预计2024年将达到34.6亿美元，复合年增长率为6.52%，预计到2030年将达到50.7亿美元。

马匹医疗保健市场涵盖广泛，专注于透过各种服务和产品来维持马匹的健康和福祉，包括治疗、兽医护理、营养食品和药物。对马医疗保健的需求源于马在运动、休閒、农业和陪伴方面提供的经济和情感价值，强调了保持最佳健康和表现的需要。该市场的应用包括疾病预防、损伤治疗、生殖健康、诊断和客製化营养计划。最终用途包括兽医诊所、牧场、赛马训练师、繁殖中心等。市场成长受到全球马匹数量不断增加、兽医技术进步、马术运动日益普及以及饲主对动物福利意识提升不断提高的影响。该市场正在见证远端医疗和穿戴式技术等数位健康解决方案提供即时健康监测和资料分析的机会激增。为了抓住这些，相关人员必须投资于物联网和人工智慧技术的集成，以创新诊断工具和个人化治疗计划。然而，先进治疗的高成本、缺乏熟练的兽医、各种法规以及发展中地区的经济限制等挑战构成了主要障碍。另一个限制是与其他畜牧业相比，市场占有率相对较小。公司应该专注于遗传疾病预防、损伤干细胞治疗以及有望获得更好效果的替代药物等研究领域。与高科技公司合作开发负担得起的兽医远端医疗解决方案也可以推动成长。总体而言，在宠物人性化和运动投资增加的推动下，马匹医疗保健市场正在不断发展，但受到成本和可及性问题的阻碍。策略伙伴关係、平价医疗解决方案的持续创新以及在新兴市场的有针对性的推广可以成为该领域显着增长和进步的催化剂。

主要市场统计
基准年[2023] 32.5亿美元
预计年份 [2024] 34.6亿美元
预测年份 [2030] 50.7亿美元
复合年增长率（%） 6.52%

市场动态：揭示快速发展的马医疗保健市场的关键市场洞察

马保健市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 马术运动日益普及，马匹用于休閒和陪伴的人数不断增加
    • 人们对动物健康和福利的认识不断增强
    • 政府和公共部门对马匹保健的财政支持
  • 市场限制因素
    • 兽医服务和先进治疗的成本上升
  • 市场机会
    • 马科疾病诊断与治疗方法的技术进步
    • 对环保和永续医疗保健产品的需求不断增长
  • 市场挑战
    • 副作用和抗药性细菌的风险

波特五力：驾驭马医疗保健市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解马保健市场的外部影响

外部宏观环境因素在塑造马保健市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解马保健市场的竞争格局

对马医疗保健市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵马医疗保健市场供应商的绩效评估

FPNV 定位矩阵是评估马医疗保健市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，为马保健市场的成功指明道路

对于旨在加强其在全球市场的影响力的公司来说，对马医疗保健市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 马术运动日益普及，为了娱乐和陪伴而拥有马匹的人数不断增加
      • 人们对动物健康和福利的认识不断增强
      • 政府和公共部门对马匹保健的财政支持
    • 抑制因素
      • 兽医服务和先进治疗费用高昂
    • 机会
      • 马科疾病诊断与治疗方法的技术进步
      • 对环保和永续医疗保健产品的需求不断增长
    • 任务
      • 药物不良反应和抗药性的风险
  • 市场区隔分析
    • 产品：广泛使用诊断工具来检测和管理马匹疾病
    • 应用：扩大马匹医疗保健在诊断、监测和治疗的应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章马保健市场：副产品

  • 诊断工具
  • 饲料补充品
    • 关节补充品
    • 维生素和矿物质
  • 药品
    • 止痛药
    • 发炎药
    • 抗生素
    • 驱虫药
    • 镇静剂
  • 疫苗

第七章马医疗保健市场：依应用分类

  • 诊断、监测和治疗
  • 外科应用

第八章马医疗保健市场：依最终用户分类

  • 兽医诊所和医院
  • 兽医研究所
  • 兽医研究组织

第九章美洲马匹保健市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太马医疗保健市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的马保健市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Neogen 宣布与 Terranova 建立生物安全合作伙伴关係
    • Hilltop Bio 推出用于马关节的 Strydaflex
    • Covetrus 推出智慧免疫蘑菇，支持马匹强大的免疫防御
  • 战略分析和建议

公司名单

  • Alltech Inc.
  • Archer-Daniels-Midland Company
  • Bayer AG
  • Belvoir Equine Limited
  • Boehringer Ingelheim International GmbH
  • Cargill, Incorporated
  • Ceva Sante Animale
  • Covetrus, Inc.
  • Dechra Pharmaceuticals PLC
  • ELANCO ANIMAL HEALTH INCORPORATED
  • ESAOTE SPA
  • Hallmarq Veterinary Imaging Inc.
  • Hilltop Biosciences
  • IDEXX Laboratories, Inc.
  • Kent Nutrition Group
  • Land O'Lakes, Inc.
  • Merck & Co., Inc.
  • Mg Biologics
  • Neogen Corporation
  • Platinum Performance, Inc.
  • Sanofi SA
  • Vetoquinol SA
  • WF Young, Inc.
  • Zoetis Inc.
Product Code: MRR-3F223D52475E

The Equine Healthcare Market was valued at USD 3.25 billion in 2023, expected to reach USD 3.46 billion in 2024, and is projected to grow at a CAGR of 6.52%, to USD 5.07 billion by 2030.

The equine healthcare market encompasses a broad scope focused on maintaining the health and well-being of horses through various services and products, including medical treatments, veterinary care, nutritional supplements, and pharmaceuticals. The necessity for equine healthcare stems from the economic and sentimental value horses provide in sports, leisure, agriculture, and companionship, emphasizing a need for optimal health and performance maintenance. This market finds applications in disease prevention, injury treatment, reproductive health, diagnostics, and customized nutrition plans. End-use scope includes animal clinics, horse farms, racehorse trainers, and breeding centers. Market growth is influenced by an increasing global equine population, technological advancements in veterinary medicine, a rise in equestrian sports popularity, and enhanced owner awareness about animal welfare. Opportunities in this market are burgeoning with digital health solutions like telemedicine and wearable tech, offering real-time health monitoring and data analytics. To seize these, stakeholders must invest in integrating IoT and AI technologies for innovations in diagnostic tools and personalized treatment plans. However, challenges such as high costs of advanced treatments, lack of skilled veterinarians, varying regulations, and economic constraints in developing regions pose significant barriers. Limitations also arise from the relatively small market share compared to other livestock sectors. Businesses should focus on research areas like genetic disease prevention, stem cell therapy for injuries, and alternative medicines that promise better outcomes. Collaborations with tech companies for developing affordable veterinary telehealth solutions could also drive growth. Overall, the equine healthcare market is evolving, driven by rising pet humanization and sports investments, yet hampered by cost and accessibility issues. Strategic partnerships, continued innovation in affordable care solutions, and targeted outreach in emerging markets can serve as a catalyst for substantial growth and advancement in this field.

KEY MARKET STATISTICS
Base Year [2023] USD 3.25 billion
Estimated Year [2024] USD 3.46 billion
Forecast Year [2030] USD 5.07 billion
CAGR (%) 6.52%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Equine Healthcare Market

The Equine Healthcare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing popularity of equine sports and increased horse ownership for leisure and companionship
    • Heightened awareness regarding animal health and welfare
    • Financial support offered by government and public organizations for equine healthcare
  • Market Restraints
    • High cost of veterinary services and advanced treatments
  • Market Opportunities
    • Technological advancements in diagnostic and treatment methods for equine diseases
    • Increasing demand for eco-friendly and sustainable healthcare products
  • Market Challenges
    • Risk of adverse drug reactions and resistance

Porter's Five Forces: A Strategic Tool for Navigating the Equine Healthcare Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Equine Healthcare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Equine Healthcare Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Equine Healthcare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Equine Healthcare Market

A detailed market share analysis in the Equine Healthcare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Equine Healthcare Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Equine Healthcare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Equine Healthcare Market

A strategic analysis of the Equine Healthcare Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Equine Healthcare Market, highlighting leading vendors and their innovative profiles. These include Alltech Inc., Archer-Daniels-Midland Company, Bayer AG, Belvoir Equine Limited, Boehringer Ingelheim International GmbH, Cargill, Incorporated, Ceva Sante Animale, Covetrus, Inc., Dechra Pharmaceuticals PLC, ELANCO ANIMAL HEALTH INCORPORATED, ESAOTE SPA, Hallmarq Veterinary Imaging Inc., Hilltop Biosciences, IDEXX Laboratories, Inc., Kent Nutrition Group, Land O'Lakes, Inc., Merck & Co., Inc., Mg Biologics, Neogen Corporation, Platinum Performance, Inc., Sanofi S.A., Vetoquinol S.A., W.F. Young, Inc., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Equine Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Diagnostics tools, Feed Supplements, Pharmaceuticals, and Vaccines. The Feed Supplements is further studied across Joint Supplements and Vitamins & Minerals. The Pharmaceuticals is further studied across Analgesics, Anti-inflammatory Drugs, Antibiotics, Antiparasitics, and Sedatives.
  • Based on Application, market is studied across Diagnosis, Monitoring & Therapy and Surgical Application.
  • Based on End-User, market is studied across Veterinary Clinics & Hospitals, Veterinary Laboratories, and Veterinary Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing popularity of equine sports and increased horse ownership for leisure and companionship
      • 5.1.1.2. Heightened awareness regarding animal health and welfare
      • 5.1.1.3. Financial support offered by government and public organizations for equine healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of veterinary services and advanced treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in diagnostic and treatment methods for equine diseases
      • 5.1.3.2. Increasing demand for eco-friendly and sustainable healthcare products
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of adverse drug reactions and resistance
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Extensive use of diagnostics tools for the detection and management of equine diseases
    • 5.2.2. Application: Increasing adoption of equine healthcare in diagnosis, monitoring & therapy
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Equine Healthcare Market, by Product

  • 6.1. Introduction
  • 6.2. Diagnostics tools
  • 6.3. Feed Supplements
    • 6.3.1. Joint Supplements
    • 6.3.2. Vitamins & Minerals
  • 6.4. Pharmaceuticals
    • 6.4.1. Analgesics
    • 6.4.2. Anti-inflammatory Drugs
    • 6.4.3. Antibiotics
    • 6.4.4. Antiparasitics
    • 6.4.5. Sedatives
  • 6.5. Vaccines

7. Equine Healthcare Market, by Application

  • 7.1. Introduction
  • 7.2. Diagnosis, Monitoring & Therapy
  • 7.3. Surgical Application

8. Equine Healthcare Market, by End-User

  • 8.1. Introduction
  • 8.2. Veterinary Clinics & Hospitals
  • 8.3. Veterinary Laboratories
  • 8.4. Veterinary Research Institutes

9. Americas Equine Healthcare Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Equine Healthcare Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Equine Healthcare Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Neogen Announced Biosecurity Partnership with TerraNova
    • 12.3.2. Hilltop Bio Launched Strydaflex for Equine Joints
    • 12.3.3. Covetrus Launches SmartImmune Mushroom to Help Support Powerful Immune Defense in Horses
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alltech Inc.
  • 2. Archer-Daniels-Midland Company
  • 3. Bayer AG
  • 4. Belvoir Equine Limited
  • 5. Boehringer Ingelheim International GmbH
  • 6. Cargill, Incorporated
  • 7. Ceva Sante Animale
  • 8. Covetrus, Inc.
  • 9. Dechra Pharmaceuticals PLC
  • 10. ELANCO ANIMAL HEALTH INCORPORATED
  • 11. ESAOTE SPA
  • 12. Hallmarq Veterinary Imaging Inc.
  • 13. Hilltop Biosciences
  • 14. IDEXX Laboratories, Inc.
  • 15. Kent Nutrition Group
  • 16. Land O'Lakes, Inc.
  • 17. Merck & Co., Inc.
  • 18. Mg Biologics
  • 19. Neogen Corporation
  • 20. Platinum Performance, Inc.
  • 21. Sanofi S.A.
  • 22. Vetoquinol S.A.
  • 23. W.F. Young, Inc.
  • 24. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. EQUINE HEALTHCARE MARKET RESEARCH PROCESS
  • FIGURE 2. EQUINE HEALTHCARE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EQUINE HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EQUINE HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. EQUINE HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EQUINE HEALTHCARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EQUINE HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EQUINE HEALTHCARE MARKET DYNAMICS
  • TABLE 7. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY DIAGNOSTICS TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY JOINT SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY SEDATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY DIAGNOSIS, MONITORING & THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY SURGICAL APPLICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY VETERINARY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY VETERINARY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY VETERINARY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. EQUINE HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. EQUINE HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023